Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1973 Sep;49(1):64–73. doi: 10.1111/j.1476-5381.1973.tb08268.x

Anti-inflammatory and some other pharmacological effects of 3,4-trans-2,2-dimethyl-3-phenyl-4-[p-(β-pyrrolidinoethoxy)-phenyl]-7- methoxy-chroman (Centchroman)

B N Dhawan, R C Srimal
PMCID: PMC1776417  PMID: 4787565

Abstract

1. Anti-inflammatory, analgesic, antipyretic and other pharmacological activities of a new chroman derivative, Centchroman, have been described.

2. Centchroman was found to possess significant anti-inflammatory action in the carrageenin-induced oedema test in mice and rats. It inhibited granuloma formation in the cotton pellet test. The anti-arthritic activity was also evident in formaldehyde-induced arthritis and adjuvant-induced arthritis in rats.

3. Centchroman had a lower ulcerogenic index than phenylbutazone.

4. The mechanism of the anti-inflammatory action of Centchroman seemed to be independent of endogenous adrenocortical hormones or of its weak oestrogenic activity.

5. Centchroman antagonized phenylquinone writhing and bradykinin-induced bronchospasm but was devoid of any antipyretic activity.

Full text

PDF
64

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIANCHI C., DAVID A. Analgesic properties of 4-ethoxycarbonyl-1-(2-hydroxy-3-phenoxypropyl) 4-phenylpiperidine (B.D.H. 20) and some related compounds. J Pharm Pharmacol. 1960 Aug;12:449–459. doi: 10.1111/j.2042-7158.1960.tb12692.x. [DOI] [PubMed] [Google Scholar]
  2. COLLIER H. O., SHORLEY P. G. Analgesic antipyretic drugs as antagonists of bradykinin. Br J Pharmacol Chemother. 1960 Dec;15:601–610. doi: 10.1111/j.1476-5381.1960.tb00288.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HARRIS J. M., SPENCER P. S. A modified plethysmographic apparatus for recording volume changes in the rat paw. J Pharm Pharmacol. 1962 Jul;14:464–466. doi: 10.1111/j.2042-7158.1962.tb11125.x. [DOI] [PubMed] [Google Scholar]
  4. Levy L. Carrageenan paw edema in the mouse. Life Sci. 1969 Jun 1;8(11):601–606. doi: 10.1016/0024-3205(69)90021-6. [DOI] [PubMed] [Google Scholar]
  5. SELYE H. Further studies concerning the participation of the adrenal cortex in the pathogenesis of arthritis. Br Med J. 1949 Nov 19;2(4637):1129-35, illust. doi: 10.1136/bmj.2.4637.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Schultzer P. Mortality of adrenalectomized young rats, with improved technique of operation, and after a period of treatment with cortical hormone. J Physiol. 1935 Apr 26;84(1):70–82.1. doi: 10.1113/jphysiol.1935.sp003257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. WHITEHOUSE M. W., HASLAM J. M. Ability of some antirheumatic drugs to uncouple oxidative phosphorylation. Nature. 1962 Dec 29;196:1323–1324. doi: 10.1038/1961323a0. [DOI] [PubMed] [Google Scholar]
  8. WINTER C. A., PORTER C. C. Effect of alterations in side chain upon anti-inflammatory and liver glycogen activities of hydrocortisone esters. J Am Pharm Assoc Am Pharm Assoc. 1957 Sep;46(9):515–519. doi: 10.1002/jps.3030460902. [DOI] [PubMed] [Google Scholar]
  9. WINTER C. A., RISLEY E. A., NUSS G. W. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 1962 Dec;111:544–547. doi: 10.3181/00379727-111-27849. [DOI] [PubMed] [Google Scholar]
  10. ZLATKIS A., ZAK B., BOYLE A. J. A new method for the direct determination of serum cholesterol. J Lab Clin Med. 1953 Mar;41(3):486–492. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES